Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yelena Mirochnik

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Drug Delivery|June 19, 2004
Two constructed antibody-derived delivery vehicles for targeting oligodeoxynucleotides to prostate tumors expressing prostate specific antigenYelena Mirochnik, Marvin Rubenstein, Patrick Guinan
Journal of Drug Targeting|June 2, 2007
Targeting of biotinylated oligonucleotides to prostate tumors with antibody-based delivery vehiclesYelena Mirochnik, Marvin Rubenstein, Patrick Guinan
Medical Oncology (Northwood, London, England)|April 1, 2003
Inhibition of PC-3 prostate cancer cell growth in vitro using both antisense oligonucleotides and taxolMarvin Rubenstein, Leonid Slobodskoy, Yelena Mirochnik, et al.
American Journal of Nephrology|October 10, 2002
Effect of relaxin in two models of renal mass reductionSandra L Garber, Yelena Mirochnik, Carolyn Brecklin, et al.
Plos One|March 10, 2012
Androgen receptor drives cellular senescenceYelena Mirochnik, Dorina Veliceasa, Latanya Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growthYelena Mirochnik, Arin Aurora, Frank T Schulze-Hoepfner, et al.
International Journal of Cancer|May 10, 2007
Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivoThomas Nelius, Stephanie Filleur, Alexander Yemelyanov, et al.
The Prostate|August 19, 2010
Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1)Li Kai, Jun Wang, Marina Ivanovic, et al.
Blood|March 6, 2010
NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacementArin B Aurora, Aryn B Aurora, Dauren Biyashev, et al.
Cancer Research|June 17, 2005
Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancerStephanie Filleur, Karl Volz, Thomas Nelius, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Drug Delivery|June 19, 2004
Two constructed antibody-derived delivery vehicles for targeting oligodeoxynucleotides to prostate tumors expressing prostate specific antigenYelena Mirochnik, Marvin Rubenstein, Patrick Guinan
Journal of Drug Targeting|June 2, 2007
Targeting of biotinylated oligonucleotides to prostate tumors with antibody-based delivery vehiclesYelena Mirochnik, Marvin Rubenstein, Patrick Guinan
Medical Oncology (Northwood, London, England)|April 1, 2003
Inhibition of PC-3 prostate cancer cell growth in vitro using both antisense oligonucleotides and taxolMarvin Rubenstein, Leonid Slobodskoy, Yelena Mirochnik, et al.
American Journal of Nephrology|October 10, 2002
Effect of relaxin in two models of renal mass reductionSandra L Garber, Yelena Mirochnik, Carolyn Brecklin, et al.
Plos One|March 10, 2012
Androgen receptor drives cellular senescenceYelena Mirochnik, Dorina Veliceasa, Latanya Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growthYelena Mirochnik, Arin Aurora, Frank T Schulze-Hoepfner, et al.
International Journal of Cancer|May 10, 2007
Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivoThomas Nelius, Stephanie Filleur, Alexander Yemelyanov, et al.
The Prostate|August 19, 2010
Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1)Li Kai, Jun Wang, Marina Ivanovic, et al.
Blood|March 6, 2010
NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacementArin B Aurora, Aryn B Aurora, Dauren Biyashev, et al.
Cancer Research|June 17, 2005
Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancerStephanie Filleur, Karl Volz, Thomas Nelius, et al.
Pageof 1